← Leaderboards
Andrea Na Amalfitano
Duke University
$3,802,601
Attributed
$3,802,601
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $529K · FY2005–14$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$3,802,601 · 4
By mechanism
R01$2,672,168 · 3
P01$1,130,433 · 1
Top collaborators
No co-investigators on record.
Most similar at Duke University
Same institution · by research overlap
- Herbert Kim Lyerly$48,598,090
- Michael Barry Kastan$65,974,699
- Duane A. Mitchell$34,257,734
- Michael A Morse$2,384,223
- Terrence Gilbert Oas$8,477,154
Others in their field
Top investigators on “Immune Response”
- Lawrence Corey · Fred Hutchinson Cancer Center$680,290,567
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,695,345
- Barton F Haynes · Duke University$456,664,915
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$309,708,725
- Peter B. Gilbert · Fred Hutchinson Cancer Center$192,329,665
Research focus
Immune ResponseTransfection /Expression VectorIn VivoAnimal ModelCytokine ReceptorsAffectFrequencies (Time Pattern)CollaborationsEnvironmental Risk FactorDiagnosisCell Culture TechniquesAnkylosing SpondylitisAntigen PresentationAntigen ProcessingAutoimmune DiseasesCultured CellsChronicAllelesBinding (Molecular Function)BiochemicalBiologicalAminopeptidaseAge Of OnsetClinically Significant
Grant awards (16)
ER-Localized Aminopeptidases in Ankylosing Spondylitis$289,578
R01 · FY2014 · AR · contact PI
ER-localized aminopeptidases in ankylosing spondylitis$280,714
R01 · FY2013 · AR · contact PI
ER-localized aminopeptidases in ankylosing spondylitis$295,488
R01 · FY2012 · AR · contact PI
ER-localized aminopeptidases in ankylosing spondylitis$295,488
R01 · FY2011 · AR · contact PI
ER-localized aminopeptidases in ankylosing spondylitis$296,100
R01 · FY2010 · AR · contact PI
Adoptive Immunotherapy with Recombinant Adenovirus Based Vectors$279,965
P01 · FY2008 · CA · contact PI
Adoptive Immunotherapy with Recombinant Adenovirus Based Vectors$278,413
P01 · FY2007 · CA · contact PI
Adenovirus vectors and complement system$250,557
R01 · FY2007 · DK · contact PI
Adenovirus vectors and complement system$258,041
R01 · FY2006 · DK · contact PI
Adoptive Immunotherapy with Recombinant Adenvirus Vector$196,349
P01 · FY2006 · CA · contact PI
Adoptive Immunotherapy with Recombinant Adenvirus Vector$190,629
P01 · FY2005 · CA
Adenovirus vectors and complement system$154,921
R01 · FY2005 · DK
Adenovirus vectors and complement system$111,501
R01 · FY2005 · DK
Adoptive Immunotherapy with Recombinant Adenvirus Vector$185,077
P01 · FY2004 · CA
MODIFIED ADENOVIRUS VECTORS FOR USE IN GENE THERAPY$223,125
R01 · FY2001 · DK
MODIFIED ADENOVIRUS VECTORS FOR USE IN GENE THERAPY$216,655
R01 · FY2000 · DK